title: [Performance of natriuretic peptide as a marker in patients with chronic obstructive pulmonary disease].
abstract: The dosage of natriuretic peptides improves diagnostic performance in patients with acute dyspnea when combined with clinical elements. The high sensitivity of this test allows reasonably excluding heart failure when the value is normal. Nevertheless, an increased level of this biomarker is not specific of heart failure and can be observed in different pathologies such as renal failure, sepsis or elevated pulmonary arterial pressure. We therefore analyse the diagnostic performance of natriuretic peptide in COPD patients and discuss its use for the detection of heart failure in this population.
authors.affiliation: Service de médecine interne générale, Département de médecine interne, réhabilitation et gériatrie, HUG, 1211 Genève 14.
authors.forename: K
authors.initials: K
authors.lastname: Gariani
authors.forename: A
authors.initials: A
authors.lastname: Perrier
authors.forename: C
authors.initials: C
authors.lastname: Marti
mesh_terms: D015415:Biomarkers / Q000097:blood; D004417:Dyspnea / Q000150:complications; D006333:Heart Failure / Q000175:diagnosis*; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood*
chemical_list: D015415:Biomarkers; D020097:Natriuretic Peptide, Brain